摘要:近日,美国食品药品监督管理局(FDA)批准了Rubraca片剂用于接受铂类化疗后有完全或部分缓解的复发性卵巢上皮癌、输卵管癌或原发性腹膜癌患者的维持治疗。根据美国国家癌症研究所(NCI)估计,每年约有2.2万多名女性被诊断为卵巢癌,其中约15%至20%的卵巢癌患者都携带BRCA基因突变。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering